A0999150
                    Moxifloxacin , 98% , 151096-09-2
CAS NO.:151096-09-2
Empirical Formula: C21H24FN3O4
Molecular Weight: 401.43
MDL number: MFCD04117996
EINECS: 604-773-0
| Pack Size | Price | Stock | Quantity | 
| 250mg | RMB112.00 | In Stock | 
                                                 | 
                                        
| 1g | RMB186.40 | In Stock | 
                                                 | 
                                        
| 5g | RMB653.60 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
Update time: 2022-07-08
                    PRODUCT Properties
| Melting point: | 203-208 C | 
                                    
| alpha | 23D -193° | 
                                    
| Boiling point: | 636.4±55.0 °C(Predicted) | 
                                    
| Density | 1.408±0.06 g/cm3(Predicted) | 
                                    
| storage temp. | 2-8°C(protect from light) | 
                                    
| solubility | Acetonitrile (Slightly), DMSO (Slightly, Heated, Sonicated), Methanol (Slightly) | 
                                    
| pka | 6.43±0.50(Predicted) | 
                                    
| form | Solid | 
                                    
| color | Off-White to Light Yellow | 
                                    
| Stability: | Hygroscopic | 
                                    
| InChIKey | FABPRXSRWADJSP-MEDUHNTESA-N | 
                                    
| SMILES | N1(C2CC2)C2=C(C=C(F)C(N3C[C@]4([H])CCCN[C@]4([H])C3)=C2OC)C(=O)C(C(O)=O)=C1 | 
                                    
| CAS DataBase Reference | 151096-09-2(CAS DataBase Reference) | 
                                    
| EPA Substance Registry System | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- (151096-09-2) | 
                                    
Description and Uses
Moxifloxacin is an antibiotic for the treatment of bacterial infections like bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
Safety
| Symbol(GHS) | ![]() GHS07  | 
                                    
| Signal word | Warning | 
| Hazard statements | H319-H302-H412 | 
| Precautionary statements | P273-P501-P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501 | 
| Hazard Codes | Xn | 
| Risk Statements | 22-40 | 
| Safety Statements | 36/37 | 
| Hazardous Substances Data | 151096-09-2(Hazardous Substances Data) | 







